Eli Lilly announced a partnership with chipmaker NVIDIA on Tuesday to build what it claims will be the “most powerful supercomputer owned and operated by a pharmaceutical company.” Lilly’s technology investment is meant to help the drugmaker tap into the potential of artificial intelligence for drug discovery.

“We want to help ensure that America wins the AI race,” said NVIDIA’s health care lead, Kimberly Powell, in an interview. “One of the most essential industries for any nation is health care, and we need to continue to lead the world in biomedical discoveries,” she added, pointing to Lilly as a global leader in discovering medicines.

Lilly’s chief information and digital officer, Diogo Rau, echoed Powell’s sentiment. “We at Lilly want to make sure that the U.S. wins the medicines ra

See Full Page